{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:22:37Z","timestamp":1791591757410,"version":"4.3.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001511","name":"Auckland Medical Research Foundation","doi-asserted-by":"publisher","award":["1116001"],"award-info":[{"award-number":["1116001"]}],"id":[{"id":"10.13039\/501100001511","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001511","name":"Auckland Medical Research Foundation","doi-asserted-by":"publisher","award":["Discovery"],"award-info":[{"award-number":["Discovery"]}],"id":[{"id":"10.13039\/501100001511","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bmc.2019.04.004","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T18:41:14Z","timestamp":1554403274000},"page":"2090-2099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["6-Bromoindolglyoxylamido derivatives as antimicrobial agents and antibiotic enhancers"],"prefix":"10.1016","volume":"27","author":[{"given":"Steven A.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M.","family":"Cadelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Sue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Blanchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Michel","family":"Brunel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Lise","family":"Bourguet-Kondracki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent R.","family":"Copp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2019.04.004_b0005","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.cell.2007.03.004","article-title":"Molecular mechanisms of antibacterial multidrug resistance","volume":"128","author":"Alekshun","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2019.04.004_b0010","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1021\/id500052s","article-title":"Solving the antibiotic crisis","volume":"1","author":"Wright","year":"2015","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmc.2019.04.004_b0015","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/509533a","article-title":"Three-step plan for antibiotics","volume":"509","author":"Anon","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2019.04.004_b0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2201","article-title":"Drugs for bad bugs: confronting the challenges of antibacterial discovery","volume":"6","author":"Payne","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2019.04.004_b0025","doi-asserted-by":"crossref","first-page":"963","DOI":"10.4155\/fmc-2016-0011","article-title":"Polyamine derivatives: a revival of an old neglected scaffold to fight resistant gram-negative bacteria?","volume":"8","author":"Blanchet","year":"2016","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmc.2019.04.004_b0030","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1128\/AAC.01472-06","article-title":"Polyamine effects on antibiotic susceptibility in bacteria","volume":"51","author":"Kwon","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2019.04.004_b0035","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1021\/jm500194e","article-title":"New ianthelliformisamine derivatives as antibiotic enhancers against resistant gram-negative bacteria","volume":"57","author":"Pieri","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.04.004_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002765","article-title":"Squalamine: an appropriate strategy against the emergence of multidrug resistant gram-negative bacteria? Romesberg F, ed","volume":"3","author":"Salmi","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2019.04.004_b0045","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/jac\/dkq031","article-title":"Squalamine, an original chemosensitizer to combat antibiotic-resistant gram-negative bacteria","volume":"65","author":"Lavigne","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmc.2019.04.004_b0050","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/jac\/dkq213","article-title":"New insights into the antibacterial mechanism of action of squalamine","volume":"65","author":"Alhanout","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmc.2019.04.004_b0055","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1021\/np1008619","article-title":"Didemnidines A and B, indole spermidine alkaloids from the New Zealand Ascidian Didemnum sp.","volume":"74","author":"Finlayson","year":"2011","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.04.004_b0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejmech.2013.07.055","article-title":"Synthesis and in vitro and in vivo evaluation of antimalarial polyamines","volume":"69","author":"Liew","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2019.04.004_b0065","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.3390\/md12063138","article-title":"Investigation of indolglyoxamide and indolacetamide analogues of polyamines as antimalarial and antitrypanosomal agents","volume":"12","author":"Wang","year":"2014","journal-title":"Mar Drugs"},{"key":"10.1016\/j.bmc.2019.04.004_b0070","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ejmech.2017.09.040","article-title":"Synthesis and antimalarial evaluation of artesunate-polyamine and trioxolane-polyamine conjugates","volume":"140","author":"Pearce","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2019.04.004_b0075","unstructured":"Galcera C, Sidhu A, Roubert P, Thurieau C. 5-Sulphanyl-4h-1,2,4-Triazole Derivatives and Their Use as Medicine. WO03045926 (A1). 2003."},{"key":"10.1016\/j.bmc.2019.04.004_b0080","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/cmdc.201800073","article-title":"Claramines: a new class of broad-spectrum antimicrobial agents with bimodal activity","volume":"13","author":"Blanchet","year":"2018","journal-title":"Chem Med Chem"},{"key":"10.1016\/j.bmc.2019.04.004_b0085","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijantimicag.2004.01.006","article-title":"Mode of action of novel polyamines increasing the permeability of bacterial outer membrane","volume":"24","author":"Yasuda","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bmc.2019.04.004_b0090","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1517\/17460441.2012.688949","article-title":"Understanding efflux in gram-negative bacteria: opportunities for drug discovery","volume":"7","author":"Schweizer","year":"2012","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.bmc.2019.04.004_b0095","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nrmicro1994","article-title":"The porin and the permeating antibiotic: a selective diffusion barrier in gram-negative bacteria","volume":"6","author":"Pag\u00e8s","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmc.2019.04.004_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154490","article-title":"Polyamino-isoprenic derivatives block intrinsic resistance of P. aeruginosa to doxycycline and chloramphenicol in vitro","volume":"11","author":"Borselli","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2019.04.004_b0105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1021\/acsinfecdis.5b00044","article-title":"Helping chemists discover new antibiotics","volume":"1","author":"Blaskovich","year":"2015","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmc.2019.04.004_b0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/md8010047","article-title":"Inhibitory activity of marine sponge-derived natural products against parasitic protozoa","volume":"8","author":"Orhan","year":"2010","journal-title":"Mar Drugs"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619302251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619302251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T20:49:26Z","timestamp":1778791766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089619302251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0968089619302251"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2019.04.004","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"6-Bromoindolglyoxylamido derivatives as antimicrobial agents and antibiotic enhancers","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2019.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}